144 results
Page 3 of 8
424B5
7jn8r7mao3iv
24 Mar 22
Prospectus supplement for primary offering
4:15pm
PRE 14A
zek9 1hkkqd4
1 Sep 21
Preliminary proxy
4:46pm
424B5
7gxzhu0
20 Aug 21
Prospectus supplement for primary offering
4:46pm
8-K
EX-1.1
2et9m47 kga
20 Aug 21
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-5.1
9oxkw
20 Aug 21
Entry into a Material Definitive Agreement
4:30pm
S-8
7ut rqsvokn
30 Jun 21
Registration of securities for employees
4:02pm
S-8
EX-5.1
meqx6
30 Jun 21
Registration of securities for employees
4:02pm
S-8
EX-23.1
b2ju2u9ee 30765
30 Jun 21
Registration of securities for employees
4:02pm
8-K
EX-10.1
xstoq99mc z29soy8e9
17 Jun 21
PROCESSA PHARMACEUTICALS ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR the Development of RX-3117
11:35am
8-K
xsigtr10olu8
10 Jun 21
Submission of Matters to a Vote of Security Holders
5:30pm
424B3
ssqiufnvvx2oux05zid3
12 Apr 21
Prospectus supplement
1:44pm
S-3
EX-23.1
10zlqfq5p10c8ejf
2 Apr 21
Shelf registration
12:00am
S-3
txatk9kwd3t gqw
2 Apr 21
Shelf registration
12:00am
S-3
EX-5.1
xwcyqz5roqd
2 Apr 21
Shelf registration
12:00am